Search

1. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

Publication:

[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2017

Subject(s):

Drug Costs
Drug Industry -- economics
Medicaid -- economics
Pharmaceutical Preparations -- classification
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

2. Classification of products as drugs and devices & additional product classification issues: final guidance : guidance for industry and FDA staff

Publication:

Silver Spring, MD : Office of Combination Products, Food and Drug Administration, September 2017

Subject(s):

Biological Products -- classification
Classification -- methods
Equipment and Supplies -- classification
Pharmaceutical Preparations -- classification
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration